{"id":"W2089572944","doi":"10.1586/14737167.2015.1017563","title":"Cost–effectiveness of therapies for melanoma","year":2015,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Dalhousie University; BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Dabrafenib; Medicine; Vemurafenib; Ipilimumab; Trametinib; Melanoma; Intensive care medicine; Cost effectiveness; Oncology; Disease; Internal medicine; Metastatic melanoma; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002922381,0.0009206306,0.002505539,0.003321837,0.0001890147,0.00153585,0.0009848375,0.001313705,0.008868388],"category_scores_gemma":[0.008093286,0.0003126128,0.00311975,0.003195948,0.0003602473,0.001113889,0.0006660872,0.001393715,0.0005405381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002764625,"about_ca_system_score_gemma":0.00264976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002948602,"about_ca_topic_score_gemma":0.004160299,"domain_scores_codex":[0.9976324,0.00107826,0.000368539,0.0001424173,0.000680745,0.00009768278],"domain_scores_gemma":[0.9964953,0.002570558,0.0005957343,0.00003736906,0.000256357,0.00004471852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004938665,0.0001010801,0.0009060334,0.08574153,0.004325754,0.0001433127,0.000038985,0.001863736,0.0003189077,0.007396628,0.01100265,0.8876675],"study_design_scores_gemma":[0.001191964,0.001255607,0.02046912,0.2467744,0.02151628,0.00459405,0.000458008,0.003135004,0.001971014,0.02443546,0.6740451,0.0001538091],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005010538,0.9969627,0.00018517,0.0007782852,0.00009774949,0.00002894544,0.000122305,0.000002782105,0.001320902],"genre_scores_gemma":[0.0129511,0.9852349,0.000702352,0.0004076661,0.0001962985,0.00006694795,0.0001285313,0.000003168053,0.0003090327],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008868388,"threshold_uncertainty_score":0.02966774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.222216366208578,"score_gpt":0.6187242438974649,"score_spread":0.396507877688887,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}